These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 16137622)

  • 1. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG.
    Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP
    Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
    Buschdorf JP; Strätling WH
    J Mol Med (Berl); 2004 Feb; 82(2):135-43. PubMed ID: 14618241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome.
    Horike S; Cai S; Miyano M; Cheng JF; Kohwi-Shigematsu T
    Nat Genet; 2005 Jan; 37(1):31-40. PubMed ID: 15608638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA.
    Chandler SP; Guschin D; Landsberger N; Wolffe AP
    Biochemistry; 1999 Jun; 38(22):7008-18. PubMed ID: 10353812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA.
    Ballestar E; Yusufzai TM; Wolffe AP
    Biochemistry; 2000 Jun; 39(24):7100-6. PubMed ID: 10852707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.
    Ballestar E; Ropero S; Alaminos M; Armstrong J; Setien F; Agrelo R; Fraga MF; Herranz M; Avila S; Pineda M; Monros E; Esteller M
    Hum Genet; 2005 Jan; 116(1-2):91-104. PubMed ID: 15549394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tight interaction between densely methylated DNA fragments and the methyl-CpG binding domain of the rat MeCP2 protein attached to a solid support.
    Shiraishi M; Sekiguchi A; Chuu YH; Sekiya T
    Biol Chem; 1999 Sep; 380(9):1127-31. PubMed ID: 10543452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in residual function of MeCP2 carrying missense mutations in the methyl CpG binding domain.
    Kudo S; Nomura Y; Segawa M; Fujita N; Nakao M; Schanen C; Tamura M
    J Med Genet; 2003 Jul; 40(7):487-93. PubMed ID: 12843318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
    Auriol E; Billard LM; Magdinier F; Dante R
    Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association by guilt: identification of DLX5 as a target for MeCP2 provides a molecular link between genomic imprinting and Rett syndrome.
    Bapat S; Galande S
    Bioessays; 2005 Jul; 27(7):676-80. PubMed ID: 15954098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
    Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
    Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl CpG-binding proteins induce large-scale chromatin reorganization during terminal differentiation.
    Brero A; Easwaran HP; Nowak D; Grunewald I; Cremer T; Leonhardt H; Cardoso MC
    J Cell Biol; 2005 Jun; 169(5):733-43. PubMed ID: 15939760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of the methyl-CpG binding domain from the chromosomal protein MeCP2.
    Nan X; Meehan RR; Bird A
    Nucleic Acids Res; 1993 Oct; 21(21):4886-92. PubMed ID: 8177735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 and other methyl-CpG binding proteins.
    Jørgensen HF; Bird A
    Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2).
    Valinluck V; Tsai HH; Rogstad DK; Burdzy A; Bird A; Sowers LC
    Nucleic Acids Res; 2004; 32(14):4100-8. PubMed ID: 15302911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.